Literature DB >> 24707128

How hepatitis C virus invades hepatocytes: the mystery of viral entry.

Yong-Zhe Zhu1, Xi-Jing Qian1, Ping Zhao1, Zhong-Tian Qi1.   

Abstract

Hepatitis C virus (HCV) infection is a global health problem, with an estimated 170 million people being chronically infected. HCV cell entry is a complex multi-step process, involving several cellular factors that trigger virus uptake into the hepatocytes. The high- density lipoprotein receptor scavenger receptor class B type I, tetraspanin CD81, tight junction protein claudin-1, and occludin are the main receptors that mediate the initial step of HCV infection. In addition, the virus uses cell receptor tyrosine kinases as entry regulators, such as epidermal growth factor receptor and ephrin receptor A2. This review summarizes the current understanding about how cell surface molecules are involved in HCV attachment, internalization, and membrane fusion, and how host cell kinases regulate virus entry. The advances of the potential antiviral agents targeting this process are introduced.

Entities:  

Keywords:  Antiviral target; Hepatitis C virus; Hepatocytes; Host kinase; Receptor; Virus entry

Mesh:

Substances:

Year:  2014        PMID: 24707128      PMCID: PMC3974512          DOI: 10.3748/wjg.v20.i13.3457

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  129 in total

1.  A human claudin-1-derived peptide inhibits hepatitis C virus entry.

Authors:  Youhui Si; Shufeng Liu; Xiuying Liu; Jana L Jacobs; Min Cheng; Yuqiang Niu; Qi Jin; Tianyi Wang; Wei Yang
Journal:  Hepatology       Date:  2012-06-11       Impact factor: 17.425

2.  A peptide derived from hepatitis C virus E2 envelope protein inhibits a post-binding step in HCV entry.

Authors:  R Liu; M Tewari; R Kong; R Zhang; P Ingravallo; R Ralston
Journal:  Antiviral Res       Date:  2010-02-13       Impact factor: 5.970

3.  Flavivirus activates phosphatidylinositol 3-kinase signaling to block caspase-dependent apoptotic cell death at the early stage of virus infection.

Authors:  Chyan-Jang Lee; Ching-Len Liao; Yi-Ling Lin
Journal:  J Virol       Date:  2005-07       Impact factor: 5.103

Review 4.  Treatment failure and resistance with direct-acting antiviral drugs against hepatitis C virus.

Authors:  Jean-Michel Pawlotsky
Journal:  Hepatology       Date:  2011-05       Impact factor: 17.425

5.  Apolipoprotein c1 association with hepatitis C virus.

Authors:  Jean-Christophe Meunier; Rodney S Russell; Ronald E Engle; Kristina N Faulk; Robert H Purcell; Suzanne U Emerson
Journal:  J Virol       Date:  2008-07-30       Impact factor: 5.103

6.  Scavenger receptor BI facilitates the metabolism of VLDL lipoproteins in vivo.

Authors:  Miranda Van Eck; Menno Hoekstra; Ruud Out; I Sophie T Bos; J Kar Kruijt; Reeni B Hildebrand; Theo J C Van Berkel
Journal:  J Lipid Res       Date:  2007-10-22       Impact factor: 5.922

7.  Polarization restricts hepatitis C virus entry into HepG2 hepatoma cells.

Authors:  Christopher J Mee; Helen J Harris; Michelle J Farquhar; Garrick Wilson; Gary Reynolds; Christopher Davis; Sven C D van IJzendoorn; Peter Balfe; Jane A McKeating
Journal:  J Virol       Date:  2009-04-08       Impact factor: 5.103

8.  Characterization of functional hepatitis C virus envelope glycoproteins.

Authors:  Anne Op De Beeck; Cécile Voisset; Birke Bartosch; Yann Ciczora; Laurence Cocquerel; Zhenyong Keck; Steven Foung; François-Loïc Cosset; Jean Dubuisson
Journal:  J Virol       Date:  2004-03       Impact factor: 5.103

9.  The postbinding activity of scavenger receptor class B type I mediates initiation of hepatitis C virus infection and viral dissemination.

Authors:  Muhammad N Zahid; Marine Turek; Fei Xiao; Viet Loan Dao Thi; Maryse Guérin; Isabel Fofana; Philippe Bachellier; John Thompson; Leen Delang; Johan Neyts; Dorothea Bankwitz; Thomas Pietschmann; Marlène Dreux; François-Loïc Cosset; Fritz Grunert; Thomas F Baumert; Mirjam B Zeisel
Journal:  Hepatology       Date:  2012-12-28       Impact factor: 17.425

Review 10.  Virus entry: open sesame.

Authors:  Mark Marsh; Ari Helenius
Journal:  Cell       Date:  2006-02-24       Impact factor: 41.582

View more
  23 in total

Review 1.  SR-B1: A Unique Multifunctional Receptor for Cholesterol Influx and Efflux.

Authors:  Wen-Jun Shen; Salman Azhar; Fredric B Kraemer
Journal:  Annu Rev Physiol       Date:  2017-11-10       Impact factor: 19.318

2.  Fine-mapping butyrophilin family genes revealed several polymorphisms influencing viral genotype selection in hepatitis C infection.

Authors:  J Ampuero; J A del Campo; L Rojas; R J García-Lozano; M Buti; R Solá; X Forns; R Moreno-Otero; R Andrade; M Diago; J Salmerón; L Rodrigo; J A Pons; J M Navarro; J L Calleja; J García-Samaniego; M García-Valdecasas; Á Rojas; R Millán; M F González-Escribano; M Romero-Gómez
Journal:  Genes Immun       Date:  2015-04-30       Impact factor: 2.676

Review 3.  Chronic hepatitis C virus infection and lipoprotein metabolism.

Authors:  Yoshio Aizawa; Nobuyoshi Seki; Tomohisa Nagano; Hiroshi Abe
Journal:  World J Gastroenterol       Date:  2015-09-28       Impact factor: 5.742

Review 4.  Hepatitis C virus: Virology, diagnosis and treatment.

Authors:  Hui-Chun Li; Shih-Yen Lo
Journal:  World J Hepatol       Date:  2015-06-08

Review 5.  HCV E2 core structures and mAbs: something is still missing.

Authors:  Matteo Castelli; Nicola Clementi; Giuseppe A Sautto; Jennifer Pfaff; Kristen M Kahle; Trevor Barnes; Benjamin J Doranz; Matteo Dal Peraro; Massimo Clementi; Roberto Burioni; Nicasio Mancini
Journal:  Drug Discov Today       Date:  2014-08-27       Impact factor: 7.851

Review 6.  Infections at the nexus of metabolic-associated fatty liver disease.

Authors:  Robim M Rodrigues; Tamara Vanhaecke; Joost Boeckmans; Matthias Rombaut; Thomas Demuyser; Baptist Declerck; Denis Piérard; Vera Rogiers; Joery De Kock; Luc Waumans; Koen Magerman; Reinoud Cartuyvels; Jean-Luc Rummens
Journal:  Arch Toxicol       Date:  2021-05-24       Impact factor: 5.153

7.  Plaque2.0-A High-Throughput Analysis Framework to Score Virus-Cell Transmission and Clonal Cell Expansion.

Authors:  Artur Yakimovich; Vardan Andriasyan; Robert Witte; I-Hsuan Wang; Vibhu Prasad; Maarit Suomalainen; Urs F Greber
Journal:  PLoS One       Date:  2015-09-28       Impact factor: 3.240

8.  A Schisandra-Derived Compound Schizandronic Acid Inhibits Entry of Pan-HCV Genotypes into Human Hepatocytes.

Authors:  Xi-Jing Qian; Xiao-Lian Zhang; Ping Zhao; Yong-Sheng Jin; Hai-Sheng Chen; Qing-Qiang Xu; Hao Ren; Shi-Ying Zhu; Hai-Lin Tang; Yong-Zhe Zhu; Zhong-Tian Qi
Journal:  Sci Rep       Date:  2016-06-02       Impact factor: 4.379

Review 9.  Hepatitis C Virus, Insulin Resistance, and Steatosis.

Authors:  Dominik Kralj; Lucija Virović Jukić; Sanja Stojsavljević; Marko Duvnjak; Martina Smolić; Ines Bilić Čurčić
Journal:  J Clin Transl Hepatol       Date:  2016-03-15

Review 10.  The Roles of RNase-L in Antimicrobial Immunity and the Cytoskeleton-Associated Innate Response.

Authors:  Heather J Ezelle; Krishnamurthy Malathi; Bret A Hassel
Journal:  Int J Mol Sci       Date:  2016-01-08       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.